Table 3.
Comparative analysis of Hematological parameters in COVID-19 patients based on survivor status
| SURVIVOR (n=473) | NON SURVIVOR (n=33) | p Value | |
|---|---|---|---|
| Hb | 11.57±2.29 | 11.77±2.23 | 0.627* |
| Hct | 37.47±6.99 | 38.3±7.15 | 0.510* |
| RBC | 4.16±0.97 | 4.34±1.02 | 0.305* |
| MCV | 90.28±12.5 | 90.03±13.81 | 0.912* |
| MCH | 28.14±3.33 | 27.76±4.22 | 0.534* |
| MCHC | 30.84±1.56 | 30.88±1.52 | 0.887* |
| RDW SD | 52.04±7.45 | 54.63±9.26 | 0.050* |
| RDW CV | 16.16±2.72 | 17.13±2.02 | 0.045* |
| WBC | 10.99±7.86 | 18.67±12.14 | <0.0001* |
| ANC | 7.96±6.28 | 14.12±7.38 | <0.0001** |
| ALC | 2.12±2.18 | 1.29±1.03 | 0.097** |
| AMC | 0.71±0.61 | 1.04±0.99 | 0.006** |
| AEC | 0.16±0.26 | 0.10±0.21 | 0.001** |
| NLR | 10.97±27.17 | 23.07±30.35 | <0.0001** |
| PLR | 147.97±132 | 211.77±153 | 0.031** |
| MLR | 0.58±1.09 | 1.07±1.52 | 0.001** |
| Platelet | 193.99±107.31 | 151±43.20 | 0.022* |
| PDW | 16.08±3.64 | 17.37±3.00 | 0.047* |
| MPV | 12.14±1.29 | 12.88±0.99 | 0.002* |
| PLCR | 41.25±9.36 | 44.95±7.63 | 0.027* |
| PCT | 0.24±0.09 | 0.22±0.07 | 0.212* |
| ESR | 25.79±7.38 | 26.76±7.29 | 0.186* |
*
independent “t” test;
**
Mann Whitney U test;
p value less than 0.05 is considered as statistically significant.
The continuous variables in the two groups i.e., survivor and non survivor were subjected to test of normality. The non normally distributed variables in two groups (survivor and non survivor) was compared using Mann Whitney U test and normally distributed variables were compared using t test.